Research Unit, Facultad de Medicina y Hospital Universitario "Dr. Jose E. Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico.
Knowledge and Evaluation Research Unit in Endocrinology, Mayo Clinic, Rochester, MN, USA.
Int J Clin Pract. 2020 Mar;74(3):e13453. doi: 10.1111/ijcp.13453. Epub 2019 Dec 9.
Insulin resistance (IR) precedes the diagnosis of many metabolic and non-metabolic illnesses, including type 2 diabetes mellitus (T2DM). Acanthosis nigricans (AN) is a clinical sign associated with IR. However, AN prevalence and diagnostic accuracy in middle-age adults before or at the time of prediabetes/diabetes diagnosis remain uncertain.
With the aim to define AN prevalence and diagnostic accuracy, adults between 40 and 60 years of age were consecutively invited to participate in the study. Participants were categorised into one of two main groups: individuals with normoglycaemia (group 1) and hyperglycaemia (group 2 [ie, prediabetes/diabetes]). Demographic, clinical, anthropometric characteristics, homeostasis model assessment of IR, homeostatic model assessment of β-cell function, as well as the presence of AN on the neck, axillae, elbows and knuckles were assessed.
A total of 320 consecutive participants with a mean age of 49.3 years (59.4% women) were included. Overall, AN prevalence was 46.3%, while AN in group 1 and group 2 was 36.3% and 49.6%, respectively (P = .04). The most common affected sites in group 1 (n = 80) were the knuckles (21.2%) and the neck (17.5%), while in group 2 (n = 240), the neck (29.6%) followed by the knuckles (26.7%). The specificity and positive predictive value of AN for IR were 0.85 and 0.86 in group 1 and 0.90 and 0.96 in group 2, respectively.
In middle-age adults, within the entire spectrum of carbohydrate tolerance, AN is highly prevalent and specific. This finding supports its assessment as a reliable and convenient clinical sign of IR. The understanding of AN behaviour through different carbohydrate tolerance strata, and its different locations, could lead to early detection of individuals at high metabolic risk or help direct a more pathophysiological treatment approach in patients with T2DM.
胰岛素抵抗(IR)先于许多代谢和非代谢疾病的诊断,包括 2 型糖尿病(T2DM)。黑棘皮症(AN)是与 IR 相关的临床征象。然而,在糖尿病前期/糖尿病诊断之前或之时,中年成年人中 AN 的患病率和诊断准确性尚不确定。
为了明确 AN 的患病率和诊断准确性,我们连续邀请了 40 至 60 岁的成年人参加研究。参与者被分为两个主要组之一:血糖正常者(第 1 组)和高血糖者(第 2 组[即糖尿病前期/糖尿病])。评估了人口统计学、临床、人体测量学特征、胰岛素抵抗的稳态模型评估、β细胞功能的稳态模型评估,以及颈、腋窝、肘部和指关节上 AN 的存在情况。
共纳入了 320 名连续参与者,平均年龄为 49.3 岁(59.4%为女性)。总体而言,AN 的患病率为 46.3%,而第 1 组和第 2 组的 AN 患病率分别为 36.3%和 49.6%(P=.04)。第 1 组(n=80)中最常见的受累部位是指关节(21.2%)和颈部(17.5%),而第 2 组(n=240)中最常见的受累部位是颈部(29.6%),其次是指关节(26.7%)。在第 1 组中,AN 对 IR 的特异性和阳性预测值分别为 0.85 和 0.86,在第 2 组中分别为 0.90 和 0.96。
在中年成年人中,在整个碳水化合物耐量范围内,AN 非常普遍且具有特异性。这一发现支持将其评估为一种可靠且方便的 IR 临床征象。通过不同的碳水化合物耐量分层以及其不同的部位来了解 AN 的行为,可能有助于早期发现代谢风险较高的个体,或有助于指导 T2DM 患者更具病理生理学的治疗方法。